Literature DB >> 3327413

The pharmacology of monoclonal antibodies.

J N Weinstein1, R R Eger, D G Covell, C D Black, J Mulshine, J A Carrasquillo, S M Larson, A M Keenan.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3327413     DOI： 10.1111/j.1749-6632.1987.tb45802.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  29 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Compartmental tissue distribution of antibody therapeutics: experimental approaches and interpretations.

Authors:  C Andrew Boswell; Daniela Bumbaca; Paul J Fielder; Leslie A Khawli
Journal:  AAPS J       Date:  2012-05-31       Impact factor: 4.009

3.  Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors.

Authors:  Shutao Wang; In Soo Shin; Hilary Hancock; Beom-su Jang; Hyung-sub Kim; Sang Myung Lee; Vesna Zderic; Victor Frenkel; Ira Pastan; Chang H Paik; Matthew R Dreher
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

Review 4.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

5.  A high-affinity protein binder that blocks the IL-6/STAT3 signaling pathway effectively suppresses non-small cell lung cancer.

Authors:  Joong-Jae Lee; Hyun Jung Kim; Chul-Su Yang; Hyun-Ho Kyeong; Jung-Min Choi; Da-Eun Hwang; Jae-Min Yuk; Keunwan Park; Yu Jung Kim; Seung-Goo Lee; Dongsup Kim; Eun-Kyeong Jo; Hae-Kap Cheong; Hak-Sung Kim
Journal:  Mol Ther       Date:  2014-03-31       Impact factor: 11.454

6.  Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1991-09       Impact factor: 4.033

7.  Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells.

Authors:  C Ballaré; M Barrio; P Portela; J Mordoh
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

8.  Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.

Authors:  I H Pastan; G E Archer; R E McLendon; H S Friedman; H E Fuchs; Q C Wang; L H Pai; J Herndon; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

Authors:  Ann-Charlott Steffen; Anna Orlova; Maria Wikman; Fredrik Y Nilsson; Stefan Ståhl; Gregory P Adams; Vladimir Tolmachev; Jörgen Carlsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

10.  Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.

Authors:  Moses Q Wilks; Scott M Knowles; Anna M Wu; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2014-07-03       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.